Methylphenidate-induced orofacial and extremity dyskinesia

Journal of Child and Adolescent Psychopharmacology

Volumn 17, Issue 3, 2007, Pages 378-381

  Balázs, Judit ^a   Besnyo, Márta ^a   Gádoros, Júlia ^a  

^a Outpatient Clinic   (Hungary)

Author keywords

Attention deficit hyperactivity disorder; Mental retardation; Stimulants

Indexed keywords

CETIRIZINE; FLUTICASONE; METHYLPHENIDATE;

AGGRESSION; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; DRUG DOSE INCREASE; DRUG EFFECT; DRUG WITHDRAWAL; DYSKINESIA; FOLLOW UP; HUMAN; INTELLIGENCE QUOTIENT; IRRITABILITY; MALE; OROFACIAL DYSKINESIA; PRESCHOOL CHILD; SIDE EFFECT; TREATMENT PLANNING;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DYSKINESIA, DRUG-INDUCED; HUMANS; MALE; METHYLPHENIDATE;

EID: 34447527521     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2006.0055     Document Type: Article

References (23)

1. Barkley RA: Attention-deficit hyperactivity disorder. In: Child Psychopathology. Edited by E.J. Mash EJ, Barkley RA, eds. New York: Guilford Press, 1996.
2. Barkley RA: International consensus statement on ADHD. J Am Acad Child Adolesc Psychiatry 41:1389, 2002.
3. Brown RT, Freeman WS, Perrin JM, Stein MT, Amler RW, Feldman HM, Pierce K, Wolraich ML: Prevalence and assessment of attention-deficit/hyperactivity disorder in primary settings. Pediatrics. 107(3):E43, 2001.
4. Case Q, Mc Andrew JB: Dexedrine dyskinesia: An unusual iatrogenic tic. Clin Pediatr Phila 13(1):69, 1974.
5. Connor DF: Stimulants and neuroleptic withdrawal dyskinesia. J Am Acad Child Adolesc Psychiatry 37(3): 247-248, 1998.
6. Gay CT, Rayn SG: Paroxsymal kinesigenic dystonia after methylphenidate administration. J Child Neurol 9(1):45-46, 1994.
7. Heinrich TW: A case report of methylphenidate-induced dyskinesia. Primary Care Companion J Clin Psychiatry 4(4):158-159, 2002.
8. Kimko HC, Cross JT, Abernethy DR: Pharmacokinetics and clinical effectiveness of methylphenidate. Clin Pharmacokinet 37:457-470, 1999.
9. Klawans HL, Weiner WJ: The effect of d-amphetamine on choreiform movement disorders. Neurology 24(4):312-318, 1974.
10. Mattson RH, Calverley JR: Dextroamphetamine-sulfate-induced dyskinesias. JAMA 29;204(5):400-402, 1968.
11. Merei F, Szakacs F: Az intelligencia mérése. (Measuring the Intelligence.) In: Pszichodiagnosztika I. Edited by Torda A. Budapest: Tankönyvkiadó, 2003, pp 13-52.
12. Pinter MM, Pogarell O, Oertal WH: Efficacy, safety and tolerance of the nonergoline dopamine agonists pramipexole in the treatment of advanced Parkinson's disease: A double blind, placebo controllled, randomised, multicentre study. J Neurol Neurosurg Psychiatry 66:36-441, 1999.
13. Sallee FR, Stiller RL, Perel JM, Everett G: Pemoline-induced abnormal involuntary movements. J Clin Psychopharmacol 9(2):125-129, 1989.
14. Santosh PJ, Taylor E: Stimulant drugs. Eur Child Adolesc Psychiatry 9(Suppl.1):I27-I43, 2000.
15. Senecky Y, Lobel D, Diamond GW, Weitz R, Inbar D: Isolated orofacial dyskinesia: A methylphenidate-induced movement disorder. Pediatr Neurol 27:224-226, 2002.
16. Singh BK, Singh A, Chusid E: Chorea in long-term use of pemoline. Ann Neurol 13(2):218, 1983.
17. Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH: A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder. Pediatrics 112(5):e404-e413, 2003.
18. Taylor E, Dopfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E, Steinhausen HC, Zuddas A: European clinical guidelines for hyperkinetic disorder - first upgrade. Eur Child Adolesc Psychiatry 13(Suppl 1):7-30, 2004.
19. Thiel A, Dressler D: Dyskinesias possibly induced by norpseudoephedrine. J Neurol 241(3):167-169, 1994.
20. Toulouse E, Piéron H: Durchstrichtest. In: Kompendium der phsychodiagnostische tests. Hiltmann H., ed. Bern (Switzerland): Huber, 1977.
21. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding Y-S, Hitzemann R, Pappas N: Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 155:1325-1331, 1998.
22. Volkow ND, Wang GJ, Fowler JS, Logan J, Franceschi D, Maynard L, Ding YS, Gatley SJ, Gifford W, Swanson JM: Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: Therapeutic implications. Synapse 43:181-187, 2002.
23. Weiner WJ, Nausieda PA, Klawans HL: Methylphenidate-induced chorea: Case report and pharmacologic implications. Neurology 28:1041-1044, 1978.